Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:10 pm Sale | 13G | Nascent Biotech Inc. NBIO | YA II PN Ltd. | 0 0% | -13,358,683 (Position Closed) | View |
| 2023-04-14 1:51 pm Purchase | 13D | Nascent Biotech Inc. NBIO | Burke Robert David | 21,272,889 16.7% | 21,272,889 (New Position) | View |
| 2023-01-03 4:09 pm Purchase | 13G | Nascent Biotech Inc. NBIO | YA II PN Ltd. | 13,358,683 9.99% | 365,837 (+2.82%) | View |
| 2022-08-31 6:45 pm Purchase | 13G | Nascent Biotech Inc. NBIO | YA II PN Ltd. | 12,992,846 9.99% | 12,992,846 (New Position) | View |
| 2021-06-21 06:10 am Purchase | 13G | Nascent Biotech Inc. NBIO | Lorio Sidney J Jr | 7,281,249 6.8% | 7,281,249 (New Position) | View |